This book investigates the application of ribozymes in the gene therapy of cancer. It explores the potential of these catalytic RNA molecules to target and degrade specific cancer-related genetic material. The work is grounded in molecular biology and biotechnology, presenting arguments for ribozymes as a novel therapeutic strategy.

This specialized text is likely aimed at researchers and advanced students in molecular biology and oncology. Its focus on ribozymes suggests a deep dive into a specific, cutting-edge area of gene therapy. The technical nature of the subject matter indicates a dense, information-rich presentation.